Cell signalling: growth factors and tyrosine kinase receptors.
about
Heme controls the regulation of protein tyrosine kinases Jak2 and SrcMolecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma.Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypes5-Formylhonokiol exerts anti-angiogenesis activity via inactivating the ERK signaling pathway.Engineered conformation-dependent VEGF peptide mimics are effective in inhibiting VEGF signaling pathways.Alternative RNA splicing and cancerClinical relevance of Ephs and ephrins in cancer: lessons from breast, colorectal, and lung cancer profiling.An open-label, phase 1 study evaluating safety, tolerability, and pharmacokinetics of linifanib (ABT-869) in Japanese patients with solid tumors.Peptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapyMelanoma cells undergo aggressive coalescence in a 3D Matrigel model that is repressed by anti-CD44.Fluorescence lifetime imaging system for in vivo studiesVEGF/VEGFR signalling as a target for inhibiting angiogenesis.Biologically targeted therapeutics in pediatric brain tumors.3,4-dihydroxyphenyl acetic acid and (+)-epoxydon isolated from marine algae-derived microorganisms induce down regulation of epidermal growth factor activated mitogenic signaling cascade in Hela cells.Melanocyte receptors: clinical implications and therapeutic relevance.Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways.Photodynamic Therapy with Hexa(sulfo-n-butyl)[60]Fullerene Against Sarcoma In Vitro and In VivoActivation of peroxisome proliferator-activated receptor-gamma by curcumin blocks the signaling pathways for PDGF and EGF in hepatic stellate cellsModulation of chemokine receptor activity through dimerization and crosstalkMimicking transient activation of protein kinases in living cells.LOX-1 and Its Splice Variants: A New Challenge for Atherosclerosis and Cancer-Targeted Therapies.Modulation of gap junction channels and hemichannels by growth factors.Growth factors and early mesoderm morphogenesis: insights from the sea urchin embryo.Lipid metabolism, apoptosis and cancer therapy.Molecular Aspects of Wound Healing and the Rise of Venous Leg Ulceration: Omics Approaches to Enhance Knowledge and Aid Diagnostic Discovery.Effects of novel maleimide derivatives on cell cultures with different properties.In vitro 3D colon tumor penetrability of SRJ09, a new anti-cancer andrographolide analog.Phase I and pharmacokinetic study of sorafenib, an oral multikinase inhibitor, in Japanese patients with advanced refractory solid tumors.Integrative analysis of cancer-related signaling pathways.Control of growth factor networks by heparan sulfate proteoglycans.Engineering NGF receptors to bind Grb2 directly uncovers differences in signaling ability between Grb2- and ShcA-binding sites.Model of vascular desmoplastic multispecies tumor growth.Anti-angiogenic activity of Herba Epimedii on zebrafish embryos in vivo and HUVECs in vitro.Essential role of mitochondrial Stat3 in p38MAPK mediated apoptosis under oxidative stress.The inhibition of epidermal growth factor receptor signaling by hexagonal selenium nanoparticles modified by SiRNA.Simulation of the regulation of EGFR endocytosis and EGFR-ERK signaling by endophilin-mediated RhoA-EGFR crosstalk.Phosphorylation of p68 RNA helicase plays a role in platelet-derived growth factor-induced cell proliferation by up-regulating cyclin D1 and c-Myc expression.
P2860
Q24305018-9FAF3412-DB28-41AB-AEAC-4991A5A871C2Q33475963-57E5649F-A2D3-4376-9918-2C19BC7D007AQ33608593-EA19C4D1-9EB4-46FB-B6AB-46A1C001846EQ34745159-670D0EFC-B3F4-467E-97F7-6A0D8720C75BQ34787415-0998A536-15C7-4027-B2B6-42F86CCAAB75Q35589667-5AFDED77-8BA9-4E2F-922A-D0D6F84E45E5Q35783568-9AD42F39-D124-42A8-A0EF-1091FF696FE3Q35996229-71247440-704E-4EB2-8AB2-B604A183F828Q36116250-DEDCF241-FA21-43DA-9DBA-F1523BB1C08CQ36298393-33A720E2-C08D-426D-9195-25E157E3DD18Q36439951-C66AB011-8760-46B2-AE1D-DF330C285472Q36677407-C4278051-7FAF-44DF-A9AF-A7D68794CA69Q36844744-BDB1B675-F86C-4152-B05D-7BA7EC25E5CEQ36905911-1B3775ED-9F11-4673-B6F8-2293A9CC321FQ36954814-71DC4DBF-FDA8-4C2E-A177-43B3FFFDAA52Q36983306-CE29A35A-4CBD-481D-9B91-9A474A364C72Q37087792-5F536AB3-F628-41D0-BEAC-939EFB3BB40EQ37170189-BF7E58B3-F87E-49D6-96AC-91CD956A313BQ37355817-198DC4EF-4C13-4374-92D4-3DE4B0EFA518Q37549801-7A8F81ED-3AA1-46EF-B9E6-49E1F2362EA2Q37690728-A7618B04-BD6B-499C-808F-A055010ACFE9Q37973241-1034B023-E6E6-4B05-974B-B68D7D13C714Q38187040-085FA433-4C12-4AD0-85ED-A42A903FE264Q38308411-AFA0B48D-157C-4AF8-8C1C-1C859A68D4A0Q38629651-658C6641-7183-48E2-8887-F8FCFEFB4FA7Q38773621-A7289928-FC82-4D0D-9691-7FA295ED38A4Q38990370-F113F848-C06E-440F-990C-919A619A9DD7Q40092301-35280E23-1F5C-47E0-B551-976B2206A713Q41458214-95F223FC-418C-4574-A42A-19E97161CD71Q41962848-642A22B8-2D4E-4E7D-8070-6682C036C87AQ42830831-E46CB558-7392-4CEA-BE9D-32FBB68A64B1Q46362794-E189181E-3AA4-4EDA-910E-B64429FF53B1Q46631510-96D365D2-0A3A-4163-B79A-105D77F766B2Q47136971-E7D61B65-4CF3-48D8-B9F6-906C190AFBA7Q50488952-0FE88095-4D25-4D21-9ECF-8419DA2BFF49Q51877889-F3B4642B-2E60-4F75-92DA-C432071FCF4BQ51989719-4327E8ED-1527-411F-99AF-36734D4F530D
P2860
Cell signalling: growth factors and tyrosine kinase receptors.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Cell signalling: growth factors and tyrosine kinase receptors.
@ast
Cell signalling: growth factors and tyrosine kinase receptors.
@en
type
label
Cell signalling: growth factors and tyrosine kinase receptors.
@ast
Cell signalling: growth factors and tyrosine kinase receptors.
@en
prefLabel
Cell signalling: growth factors and tyrosine kinase receptors.
@ast
Cell signalling: growth factors and tyrosine kinase receptors.
@en
P1476
Cell signalling: growth factors and tyrosine kinase receptors.
@en
P2093
Rosario Perona
P2888
P356
10.1007/S12094-006-0162-1
P577
2006-02-01T00:00:00Z